LSAG
ATRA icon

Lake Street Advisors Group’s Atara Biotherapeutics ATRA Stock Holding History

Lake Street Advisors Group’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,000
Closed -$93.5K – 647
2024
Q2 		$93.5K Buy
11,000
+10,560
+2,400% +$159K ﹤0.01% 558
2024
Q1 		$7.63K Hold
440
– – ﹤0.01% 656
2023
Q4 		$5.64K Sell
440
-22
-5% -$513 ﹤0.01% 647
2023
Q3 		$17K Hold
462
– – ﹤0.01% 339
2023
Q2 		$19K Hold
462
– – ﹤0.01% 331
2023
Q1 		$34K Buy
+462
New +$44.8K ﹤0.01% 285

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lake Street Advisors Group's ATRA Position: Q3 2024 in Review

Lake Street Advisors Group sold out of Atara Biotherapeutics (ATRA) in Q3 2024, closing a stake of 11,000 shares — an estimated $93.5K sold.

Lake Street Advisors Group first reported a position in ATRA in Q1 2023 and held it in 6 quarters. The position peaked at $93.5K in Q2 2024. 35 funds tracked by Wall St. Rank hold ATRA as of Q3 2024.

  • Lake Street Advisors Group reported no remaining Atara Biotherapeutics position as of Q3 2024 after selling out during the quarter.
  • Lake Street Advisors Group sold 11,000 Atara Biotherapeutics shares in Q3 2024, an estimated $93.5K.
  • Lake Street Advisors Group first reported a position in Atara Biotherapeutics in Q1 2023 and held it in 6 quarters.
  • Lake Street Advisors Group's Atara Biotherapeutics position peaked at $93.5K in Q2 2024.
  • 35 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2024.

Based on Lake Street Advisors Group's 13F filing for Q3 2024, filed 23 Oct 2024.